Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis

Free Subscription 18.02.2019 1 Dig Dis Sci 1 Gastroenterology 1 J Clin Microbiol 2 J Hepatol 1 J Infect Dis 3 J Med Virol 2 J Pediatr 6 J Viral Hepat 2 Lancet 1 MMWR Morb Mortal Wkly Rep 2 N Engl J Med 4 PLoS One 2 Vaccine 1 Virology 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Dig Dis Sci

1. WU T, Konyn PG, Cattaneo AW, Saab S, et al
   New Face of Hepatitis C.
   Dig Dis Sci. 2019 Feb 13. pii: 10.1007/s10620-019-05511.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

2. KARIMZADEH H, Kiraithe MM, Oberhardt V, Alizei ES, et al
   Mutations in Hepatitis D Virus Allow it to Escape Detection by CD8+ T Cells and Evolve at the Population Level.
   Gastroenterology. 2019 Feb 12. pii: S0016-5085(19)30366.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Microbiol

3. WEBER J, Sahoo MK, Taylor N, Shi RZ, et al
   Evaluation of the Aptima HCV Quant Dx Assay using Serum and Dried Blood Spots.
   J Clin Microbiol. 2019 Feb 13. pii: JCM.00030-19. doi: 10.1128/JCM.00030.
   PubMed     Text format     Abstract available
   
   

   
   J Hepatol

4. KEMMING J, Reeves E, Nitschke K, Widmeier V, et al
   ERAP1 allotypes impact the epitope repertoire of virus-specific CD8(+) T cell responses in acute hepatitis C virus infection.
   J Hepatol. 2019 Feb 12. pii: S0168-8278(19)30111.
   PubMed     Text format     Abstract available
   
   
5. BANDA DH, Perin PM, Brown RJP, Todt D, et al
   A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors.
   J Hepatol. 2019 Feb 12. pii: S0168-8278(19)30110.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

6. SALAZAR-VIZCAYA L, Kouyos RD, Metzner KJ, Caraballo Cortes K, et al
   Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up era.
   J Infect Dis. 2019 Feb 13. pii: 5318573. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Med Virol

7. BARFI S, Poortahmasebi V, Ofoghi H, Farahmand M, et al
   Measurement of serum hepatitis B surface antibody (HBs-Ab) levels in Iranian autistic children and evaluation of immunological memory after booster dose injection in comparison with controls.
   J Med Virol. 2019 Feb 13. doi: 10.1002/jmv.25429.
   PubMed     Text format     Abstract available
   
   
8. HUANG Y, Wang B, Peng Z, Tang N, et al
   Hepatitis B virus Surface gene mutants in immunoprophylaxis-failed infants from Southern China.
   J Med Virol. 2019 Feb 13. doi: 10.1002/jmv.25430.
   PubMed     Text format     Abstract available
   
   
9. HETTA HF, Zahran AM, Mansor SG, Abdel-Malek MO, et al
   Frequency and Implications of Myeloid Derived Suppressor Cells and Lymphocyte Subsets in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
   J Med Virol. 2019 Feb 13. doi: 10.1002/jmv.25428.
   PubMed     Text format     Abstract available
   
   

   
   J Pediatr

10. NGUYEN J, Barritt Iv AS, Jhaveri R
    Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection.
    J Pediatr. 2019 Feb 6. pii: S0022-3476(18)31729.
    PubMed     Text format     Abstract available
    
    
11. CHAPIN CA, Horslen SP, Squires JE, Lin H, et al
    Corticosteroid Therapy for Indeterminate Pediatric Acute Liver Failure and Aplastic Anemia with Acute Hepatitis.
    J Pediatr. 2019 Feb 12. pii: S0022-3476(18)31816.
    PubMed     Text format     Abstract available
    
    

    
    J Viral Hepat

12. GIADANS CG, Rios DA, Ameigeiras B, Pietrantonio AM, et al
    Chronic Hepatitis B: The interplay between intrahepatic lymphocyte population and viral antigens in relation to liver damage.
    J Viral Hepat. 2019 Feb 9. doi: 10.1111/jvh.13078.
    PubMed     Text format     Abstract available
    
    
13. PALAZZO D, Biliotti E, Esvan R, Volpicelli L, et al
    Vitamin D deficiency and health-related quality of life in chronic hepatitis C.
    J Viral Hepat. 2019 Feb 9. doi: 10.1111/jvh.13076.
    PubMed     Text format     Abstract available
    
    
14. FERENCI P, Bourgeois S, Buggisch P, Norris S, et al
    Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir +/- dasabuvir +/- ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observation
    J Viral Hepat. 2019 Feb 10. doi: 10.1111/jvh.13080.
    PubMed     Text format     Abstract available
    
    
15. LAWITZ E, Poordad F, Anderson LJ, Vesay M, et al
    Efficacy and Safety of Ruzasvir 60 mg and Uprifosbuvir 450 mg for 12 Weeks in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection.
    J Viral Hepat. 2019 Feb 9. doi: 10.1111/jvh.13079.
    PubMed     Text format     Abstract available
    
    
16. SHYU YC, Huang TS, Chien CH, Yeh CT, et al
    Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: a population-based cohort study.
    J Viral Hepat. 2019 Feb 9. doi: 10.1111/jvh.13077.
    PubMed     Text format     Abstract available
    
    
17. IDILMAN R, Demir M, Aladag M, Erol C, et al
    Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort.
    J Viral Hepat. 2019 Feb 11. doi: 10.1111/jvh.13075.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

18. CARRAT F, Fontaine H, Dorival C, Simony M, et al
    Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32111.
    PubMed     Text format     Abstract available
    
    
19. HOLMES JA, Rutledge SM, Chung RT
    Direct-acting antiviral treatment for hepatitis C.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32326.
    PubMed     Text format    
    
    

    
    MMWR Morb Mortal Wkly Rep

20. DOSHANI M, Weng M, Moore KL, Romero JR, et al
    Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness.
    MMWR Morb Mortal Wkly Rep. 2019;68:153-156.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

21. DA FONSECA EM, Shadlen K, Bastos FI
    Brazil's Fight against Hepatitis C - Universalism, Local Production, and Patents.
    N Engl J Med. 2019;380:605-607.
    PubMed     Text format    
    
    
22. MOON S, Erickson E
    Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to Hepatitis C.
    N Engl J Med. 2019;380:607-610.
    PubMed     Text format    
    
    

    
    PLoS One

23. HANSEN JF, Christiansen KM, Staugaard B, Moessner BK, et al
    Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C.
    PLoS One. 2019;14:e0212036.
    PubMed     Text format     Abstract available
    
    
24. YANG RF, Liu Y, Zhao CY, Ding YX, et al
    A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals?
    PLoS One. 2019;14:e0211795.
    PubMed     Text format     Abstract available
    
    
25. ARENDS RM, Nelwan EJ, Soediro R, van Crevel R, et al
    Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study.
    PLoS One. 2019;14:e0207970.
    PubMed     Text format     Abstract available
    
    
26. ABEL S, Cuzin L, Da Cunha S, Bolivard JM, et al
    Reaching the WHO target of testing persons in jails in prisons will need diverse efforts and resources.
    PLoS One. 2018;13:e0202985.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

27. RAMSAY LC, Anyiwe K, Li M, Macdonald L, et al
    Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30155.
    PubMed     Text format     Abstract available
    
    
28. SHARP A, Coles S, Pegorie M, Harwood C, et al
    Vaccination strategies for control of community outbreaks of hepatitis A: A comparison of two outbreaks in England.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30089.
    PubMed     Text format     Abstract available
    
    

    
    Virology

29. SUZUKI R, Matsuda M, Shimoike T, Watashi K, et al
    Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase.
    Virology. 2019;529:226-233.
    PubMed     Text format     Abstract available
    
    

    
    Z Gastroenterol

30. MAUSS S, Buendgens L, Christensen S, Ingiliz P, et al
    Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C.
    Z Gastroenterol. 2019;57:139-147.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: